BCL2 dependency in diffuse large B-cell lymphoma: it's a family affair

被引：3
|
作者：
Matulis, Shannon M.
Boise, Lawrence H. [1 ,2 ]
机构：
[1] Emory Univ, Emory Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[2] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
来源：
HAEMATOLOGICA | 2020年 / 105卷 / 08期
关键词：
CLINICAL-RESPONSE; NON-HODGKIN; SENSITIVITY; VENETOCLAX;
D O I：
10.3324/haematol.2020.253591
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1993 / 1996
页数：4
相关论文
共 50 条
  • [21] Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients
    Yuan, Ji
    Liu, Hui
    Hu, Shimin
    Miranda, Roberto N.
    Xu, Xinjie
    Bayerl, Michael G.
    Artymiuk, Cody J.
    Berg, Holly
    King, Rebecca L.
    Shi, Min
    He, Rong
    Viswanatha, David
    Medeiros, L. Jeffrey
    Mcphail, Ellen D.
    HUMAN PATHOLOGY, 2023, 141 : 22 - 29
  • [22] Prognostic outcomes of diffuse large B-cell lymphoma patients with myelocytomatosis oncogene (MYC) and B-cell lymphoma 2 (BCL2) co-expression
    Supanut Kumjan
    Kantang Satayasoontorn
    Kasidid Lawongsa
    Chonlada Laoruangroj
    Journal of Hematopathology, 2025, 18 (1)
  • [23] BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma
    Iqbal, J
    Neppalli, VT
    Wright, G
    Dave, LJ
    Horsman, DE
    Rosenwald, A
    Lynch, J
    Hans, CP
    Weisenburger, DD
    Greiner, TC
    Gascoyne, RD
    Campo, E
    Ott, G
    Müller-Hermelink, HK
    Delabie, J
    Jaffe, ES
    Grogan, TM
    Connors, JM
    Vose, JM
    Armitage, JO
    Staudt, LM
    Chan, WC
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) : 961 - 968
  • [24] Coexistent Rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma
    Ueda, C
    Nishikori, M
    Kitawaki, T
    Uchiyama, T
    Ohno, H
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (01) : 52 - 54
  • [25] MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
    Horn, Heike
    Ziepert, Marita
    Becher, Claudia
    Barth, Thomas F. E.
    Bernd, Heinz-Wolfram
    Feller, Alfred C.
    Klapper, Wolfram
    Hummel, Michael
    Stein, Harald
    Hansmann, Martin-Leo
    Schmelter, Christopher
    Moeller, Peter
    Cogliatti, Sergio
    Pfreundschuh, Michael
    Schmitz, Norbert
    Truemper, Lorenz
    Siebert, Reiner
    Loeffler, Markus
    Rosenwald, Andreas
    Ott, German
    BLOOD, 2013, 121 (12) : 2253 - 2263
  • [26] Novel Targeting Of BCL2 and MYC DNA Secondary Structures In Diffuse Large B-Cell Lymphoma (DLBCL)
    Kendrick, Samantha L.
    Loftin, Crystal
    Rivera, Xavier
    Hurley, Laurence H.
    Rimsza, Lisa M.
    BLOOD, 2013, 122 (21)
  • [27] Primary cutaneous diffuse large B-cell lymphoma, leg type with MYC/BCL2/BCL6 overexpression
    Okada, Yosuke
    Sone, Takehiro
    Takada, Kohei
    Ogata, Hiraku
    Saito, Keita
    Kimura, Fumihiko
    EJHAEM, 2022, 3 (01): : 251 - 251
  • [28] Expression Signature and Prognostic Value of BCL2 Translocation for Diffuse Large B-Cell Lymphoma Patients in China
    Qin, Yan
    Qiu, Tian
    Chen, Xinrui
    Liu, Peng
    Yang, Jianliang
    He, Xiaohui
    Gui, Lin
    Zhou, Shengyu
    Jiang, Hongxin
    Zhang, Changgong
    Yang, Sheng
    Tang, Le
    Shi, Yuankai
    BLOOD, 2022, 140 : 12094 - 12095
  • [29] Dual expression of MYC and BCL2 proteins predicts worse outcomes in diffuse large B-cell lymphoma
    Schneider, Kelli M. Clark
    Banks, Peter M.
    Collie, Angela M. B.
    Lanigan, Christopher P.
    Manilich, Elena
    Durkin, Lisa M.
    Hill, Brian T.
    Hsi, Eric D.
    LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1640 - 1648
  • [30] Impact of BCL2 Mutations to BCL2 Protein Expression in B-Cell Lymphoma
    Baik, Jeeyeon
    Isgor, Irem
    Aypar, Umut
    Dogan, Ahmet
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1096 - S1097
12345